Диссертация (1139499), страница 46
Текст из файла (страница 46)
Kirchengast S. Postmenopausal weight status, body composition and body fatdistribution in relation to parameters of menstrual and reproductive history./Kirchengast S. [et al]// Maturitas. – 1999. – Vol.33. – P.117–26350. Kittikulsuth W. ET-1 actions in the kidney: evidence for sex differences./Kittikulsuth W., Sullivan JC, Pollock DM.// Br J Pharmacol. – 2013. – Vol.168. –P.318-26.351. Kittner SJ.
Pregnancy and the risk of stroke./ Kittner SJ [et al]// N Engl J Med. –1996. – Vol.335. – P.768 –774.352. Knowlton AA, Lee AR. Estrogen and the cardiovascular system./ Knowlton AA,Lee AR. // Pharmacol Ther. – 2012. – Vol.135. – P.54-70.353. Kocak H. Serum asymmetric dimehylarginine and nitric oxide levels in obesepostmenopausal women./ Kocak H [et al]// J Clin Lab Anal. – 2011. –Vol.25(3). –P.174-8354. Kohan D.E. Endothelins in the normal and diseased kidney./ Kohan D.E.
// Am JKidney Dis. – 1996. – Vol.1. – P.2-26.355. Korda M. Leptin-induced endothelial dysfunction in obesity./ Korda M. [et al]//Am J Physiol Heart Circ Physiol. – 2008. – Vol.295. – P.H1514–21.356. Koren MJ. Relation of left ventricular mass and geometry to morbidity andmortality in uncomplicated essential hypertension./ Koren MJ [et al]// Ann Intern Med.– 1991. – Vol.114. – P.345-52.357. Kramer HM. Hemodialysis and Estrogen Levels in Postmenopausal PatientsStudy Group. Permanent cessations of menses and postmenopausal hormone use indialysis-dependent women: the HELP study/ Kramer HM, Curhan GC, Singh A.
// Am JKidney Dis. – 2003. – Vol.3(43). – P.643-50.358. Krumholz HM. Sex differences in cardiac adaptation to isolated systolichypertension./ Krumholz HM, Larson M, Levy D. // Am J Cardiol. – 1993. – Vol.72. –P.310-3.359. Kuch B. Gender specific differences in left ventricular adaptation to obesity andhypertension./ Kuch B [et al]// J Human Hypertens. – 1998. – Vol.12. –P.685-91.289360.
Kuo JJ. Inhibition of NO synthesis enhances chronic cardiovascular and renalactions of leptin./ Kuo JJ, Jones OB, Hall JE. // Hypertens. – 2001. – Vol.37. – P.670–6.361. Laaksonen DE. Testosterone and sex-hormone-binding globulin predict themetabolic syndrome and diabetes in middle-aged men/ Laaksonen DE [et al] // DiabetesCare.
– 2004 . – Vol.27. - P.1036-1041.362. Lacy F. Plasma hydrogen peroxide production in human essential hypertension:role of heredity, gender, and ethnicity./ Lacy F. [et al]// Hypertension. – 2000. – Vol.36.– P.878-84.363. Lambert LJ. Health status of users hormone replacement therapy by hysterectomystatus in Western Australia./ Lambert LJ [et al]// J Epidemiol Community Health. –2003. – Vol.57. – P.294-300.364. Laughlin GA. Hysterectomy, oophorectomy, and endogenous sex hormone levelsin older women: the Rancho Bernardo study./ Laughlin GA. [et al]// J Clin EndocrinolMetab.
– 2000. – Vol.85. – P.645-51.365. Laughlin MH. Interaction of gender and exercise training: vasomotor reactivity ofporcine skeletal muscle arteries./ Laughlin MH [et al]// J Appl Physiol. – 2001. –Vol.90(1). – P.216-27.366. Lekakis J. Methods for evaluating endothelial function: a position statement fromthe European Society of Cardiology Working Group on Peripheral Circulation/ LekakisJ [at al.] //Eur J Cardiovasc Prev Rehabil.
– 2011. – Vol. 18(6). – P.775-89.367. Lekontseva O. Endothelin in the female vasculature: a role in aging?/ LekontsevaO, Chakrabarti S, Davidge T. // Am J Physiol Regul Integr Comp Physiol. – 2010. –Vol.298. – P.R509-16.368. Lekontseva O. Role of neuronal nitric-oxide synthase in estrogen-inducedrelaxation in rat resistance arteries./ Lekontseva O [et al]// J Pharmacol Exp Ther.
–2011. – Vol.339. – P.367-75.369. Lemos CS. Chronic renal failure in male and female rats/ Lemos C.S. [et al] // JNephrol. – 2005. – Vol. 18. – №4. – P. 368-373.290370. Leonetti G. Is systolic pressure a better target for antihypertensive treatment thandiastolic pressure?/ Leonetti G [et al]// J Hypertens. – 2000. – Vol.18(Suppl. 3). – P.13–20.371. Levi M. Renal function and dysfunction in aging./ Levi M, Rowe JW.// TheKidney: Physiology and Pathophysiology. Seldin DW, Giebisch G, eds. - New York. Raven Press.
– 1992. – P.3433–3456. 372. Levitzky YS. Impact of impaired fasting glucose on cardiovascular disease: theFramingham Heart Study./ Levitzky YS [et al]// J Am Coll Cardiol. – 2008. –Vol.51(3).– P.264–270.373. Lewis C.E. Efficacy and tolerance of antihypertensive treatment in men andwomen with stage 1 diastolic hypertension./ Lewis C.E. [et al]// Arch Intern Med.
–1996. – Vol.156. – P.377-85.374. Lhotta K. Cigarette smoking and vascular pathology in renal biopsies./ Lhotta K.[et al]// Kidney Int. – 2002. – Vol. 61. – P. 648 – 654.375. Liao Y. Continuous Relation Between Left Ventricular Mass and CardiovascularRisk in Essential Hypertension./ Liao Y. [et al]// Hypertension. – 2000. – Vol.35(2). –P.580–6.376.
Lieberman E.H. Estrogens improves endothelium-dependent, flow-mediatedvasodilatation in postmenopausal women./ Lieberman E.H. [et al]// Ann Intern Med. –1994. – Vol.121. – P.936-42.377. Liebson PR. Echocardiographic Correlates of Left Ventricular Structure Among844 Mildly Hypertensive Men and Women in the Treatment of Mild HypertensionStudy (TOMHS)/ Liebson PR [et al]// Circulation. – 1993.
–Vol.87(2). – P.476–86.378. Lindeman RD. Longitudinal studies on the rate of decline in renal function withage./ Lindeman RD, Tobin J, Shock NW.// J Am Geriatr Soc. – 1985. – Vol.33. –P.278–285.379. Liu J. Leptinemia and its association with stroke and coronary heart disease in theJackson Heart Study./ Liu J [et al]// Clin Endocrinol. – 2010. – Vol.72.
– P.32–7.380. Liu PY. Androgens and cardiovascular disease./ Liu PY, Death AK, HandelsmanDJ. // Endocr Rev. – 2003. – Vol.24(3). – P.313-340.291381. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics./ Liu Y.// Kidney Int. – 2006.
– Vol.69. – P.213-7.382. Lloyd-Jones DM. Hypertension in adults across the age spectrum: currentoutcomes and control in the community./ Lloyd-Jones DM, Evans JC, Levy D. //JAMA. – 2005. – Vol.294. – P. 466–472.383. Lloyd-Jones DM. Lifetime risk for developing congestive heart failure: theFramingham Heart Study./ Lloyd-Jones DM [et al]// Circulation. – 2002. – Vol.106. –P.3068-3072.384. Loikas D. Differences in drug utilisation between men and women: a crosssectional analysis of all dispensed drugs in Sweden./ Loikas D. [et al]// BMJ Open. –2013. – Vol.3(5). - P.
e002378.385. Lunenfeld B. ISA, ISSAM, and EAU recommendations for the investigation,treatment and monitoring of late-onset hypogonadism in males: scientific backgroundand rationale/ Lunenfeld B, Saad F, Hoesl CE. // Aging Male. – 2005. – Vol.8(2). –P.59-74..386. Luoto R. Cardiovascular morbidity in ration to ovarian function afterhysterectomy./ Luoto R. [et al]// Obstet Gynecol. – 1995.
– Vol.85(4). – P.515-22.387. Luukkaa V. Inverse Correlation between Serum Testosterone and Leptin in Men./Luukkaa V. [et al]// J Clin Endocrinol Metab. – 1998. – Vol.83. – P.3243-6.388. Luzier AB. Gender-related effects on metoprolol pharmacokinetics andpharmacodynamics in healthy volunteers./ Luzier AB [et al].// Clin Pharmacol Ther. –1999. – Vol.66. – P.594–601.389. Macdonald IA. Advances in our understanding of the role of the sympatheticnervous system in obesity./ Macdonald IA. // Int J Obes. – 1995. – Vol.19(7).
– P.S2–S7.390. Madeddu P. Regulation of bradykinin B2-receptor expression by oestrogen./Madeddu P. [et al]// Br J Pharmacol. – 1997. – Vol.121. – P.1763–1769.391. Maggio M. Correlation between testosterone and the inflammatory markersoluble interleukin–6 receptor in older men./ Maggio M.
[et al] // J Clin EndocrinolMetab. – 2006. – Vol.91(1). – P.345–7.292392. Majmudar NG. Effect of the Menopause, Gender and Hormone ReplacementTherapy on Vascular Nitric Oxide Activity./ Majmudar NG, Robinson SC, Ford GA.// JClin Endocrinol Metabol. – 2000. – Vol.85(4). – P.1577-83.393. Makek AM. Hemodynamic shear stress and its role in atherosclerosis./ MakekAM, Alper SL, Izumo S.// JAMA. – 1999.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
